| 000 | 01552 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511181754.0 | ||
| 264 | 0 | _c19920228 | |
| 008 | 199202s 0 0 eng d | ||
| 022 | _a0143-3334 | ||
| 024 | 7 |
_a10.1093/carcin/13.1.87 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFortini, P | |
| 245 | 0 | 0 |
_aMethoxyamine modification of abasic sites protects CHO cells from the cytotoxic and mutagenic effects of oxygen alkylation. _h[electronic resource] |
| 260 |
_bCarcinogenesis _cJan 1992 |
||
| 300 |
_a87-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlkylating Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCHO Cells _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 | _aDNA-(Apurinic or Apyrimidinic Site) Lyase |
| 650 | 0 | 4 | _aDeoxyribonuclease IV (Phage T4-Induced) |
| 650 | 0 | 4 |
_aEndodeoxyribonucleases _xpharmacology |
| 650 | 0 | 4 |
_aHydroxylamines _xpharmacology |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOligonucleotides _xmetabolism |
| 650 | 0 | 4 |
_aOxygen _xmetabolism |
| 650 | 0 | 4 |
_aSister Chromatid Exchange _xdrug effects |
| 700 | 1 | _aRosa, S | |
| 700 | 1 | _aZijno, A | |
| 700 | 1 | _aCalcagnile, A | |
| 700 | 1 | _aBignami, M | |
| 700 | 1 | _aDogliotti, E | |
| 773 | 0 |
_tCarcinogenesis _gvol. 13 _gno. 1 _gp. 87-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/carcin/13.1.87 _zAvailable from publisher's website |
| 999 |
_c1377261 _d1377261 |
||